Grant: Team Grant: CRISM Phase II: Regional Nodes
University of British Columbia
$2,400,000.00
Canadian Research Initiative in Substance Misuse: BC Node
FY 2021-22
Summary
Despite the enormous burden of disease attributable to harmful drug and alcohol use, major challenges remain in implementing evidence-based interventions for substance use (SU) and substance use disorders (SUD). While notable research advances have been made in understanding effective pharmacological and psychosocial approaches to SUD, many evidence-based approaches remain under-utilized. Pragmatic clinical trials and clinical implementation science research can identify new interventions and facilitate scale-up of effective interventions to maximize population impact. Given our accomplishments over the past 6 years, the BC Node is ideally positioned to maintain its role as the hub for the BC network and partner to the other regional Nodes. Our team includes a diverse network of knowledge users, service providers, representatives of the affected community, decision makers, and research scientists, which makes us well-suited to undertake collaborative research and implement evidence-based approaches to substance use. Building on past achievements and utilizing our vast research and training infrastructure, we seek to fulfill the following objectives for the next phase of CRISM:
-Support the improvement in the quality of care and quality of life for people with SUD
-Identify and/or develop effective and scalable clinical and community-based prevention and treatment interventions and guidelines, including harm reduction, for SU
-Provide evidence to decision makers and service providers to enhance prevention and treatment services, as well as policy development, regarding SU
-Engage Indigenous Peoples in research and knowledge translation (KT) efforts in a manner respecting the rights of Indigenous Peoples and Indigenous self-determination and self-governance
-Involve individuals with lived and living experience throughout network activities
-Develop training programs to build research capacity
-Develop a methamphetamine use disorder treatment randomized clinical trial
Department
Program
Team Grant: CRISM Phase II: Regional Nodes
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
459740
Name
Wood Evan
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Team Grant: CRISM Phase II: Regional Nodes
Projecttitle
Canadian Research Initiative in Substance Misuse: BC Node
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$2,400,000
Cihrequipment2
$0
Programname2
Team Grant: CRISM Phase II: Regional Nodes
Keyworddelim
Addiction; Clinical Trials; Hiv/Aids; Substance Use
Abstract
Despite the enormous burden of disease attributable to harmful drug and alcohol use, major challenges remain in implementing evidence-based interventions for substance use (SU) and substance use disorders (SUD). While notable research advances have been made in understanding effective pharmacological and psychosocial approaches to SUD, many evidence-based approaches remain under-utilized. Pragmatic clinical trials and clinical implementation science research can identify new interventions and facilitate scale-up of effective interventions to maximize population impact. Given our accomplishments over the past 6 years, the BC Node is ideally positioned to maintain its role as the hub for the BC network and partner to the other regional Nodes. Our team includes a diverse network of knowledge users, service providers, representatives of the affected community, decision makers, and research scientists, which makes us well-suited to undertake collaborative research and implement evidence-based approaches to substance use. Building on past achievements and utilizing our vast research and training infrastructure, we seek to fulfill the following objectives for the next phase of CRISM:
-Support the improvement in the quality of care and quality of life for people with SUD
-Identify and/or develop effective and scalable clinical and community-based prevention and treatment interventions and guidelines, including harm reduction, for SU
-Provide evidence to decision makers and service providers to enhance prevention and treatment services, as well as policy development, regarding SU
-Engage Indigenous Peoples in research and knowledge translation (KT) efforts in a manner respecting the rights of Indigenous Peoples and Indigenous self-determination and self-governance
-Involve individuals with lived and living experience throughout network activities
-Develop training programs to build research capacity
-Develop a methamphetamine use disorder treatment randomized clinical trial
Competitiondate
202202
Approvedterm2
6 yrs 0 mth
Pinamesdelim
Wood, Evan; Tupper, Kenneth; Fairbairn, Nadia S; Johnson, Cheyenne H; Nolan, Seonaid; Socías, María E
Approvedterm
6 ans 0 mois
Cihrcontribution2
~ $2,400,000~ $0~